Intravenous thrombolysis in ischemic stroke: 10 rules for the practical neurologist
https://doi.org/10.21518/2079-701X-2022-16-21-175-183
Abstract
Intravenous thrombolysis (IT) with recombinant tissue plasminogen activator has remained the main method of reperfusion therapy in ischaemic stroke for a quarter of a century. The main trends in the use of IT in recent years are the expansion of the therapeutic window using additional methods of neuroimaging, reducing the number of contraindications and introduction into clinical practice of bolus forms of drugs. Providing IT to the largest number of patients should be considered a major challenge for the primary vascular department. This article presents 10 clinical rules for extending IT in stroke while ensuring its efficacy and safety: 1) conduct IT in suspected stroke; 2) conduct IT in patients over 80 (and even 90) years of age; 3) conduct IT in minor but disabling stroke; 4) conduct IT in minor vertebrobasilar stroke and central acute vestibular syndrome; 5) perform IT in cases of large artery occlusion; 6) perform IT in suspected lacunar stroke and chronic neuroimaging changes (lacunas, white matter hyperintensity, atrophy); 7) reduce door-to-needle time, use thrombolytics with bolus administration; 8) use neuroimaging options (CT perfusion, MR perfusion, MR DWI/FLAIR) to expand the therapeutic window; 9) ensure the safety of IT; 10) be prepared for complications. Increasing the frequency of IT should not be seen as a goal, but intensifying the use of this method of treatment is associated with the improvement of all areas of the diagnostic and treatment process in the clinic and the improvement of stroke outcomes.
About the Authors
А. А. Кulesh
Vagner Perm State Medical University
Russian Federation
Russian Federation
Аlexey А. Кulesh, Dr. Sci. (Med.), Associate Professor, Professor of the Department of Neurology and Medical Genetics
26, Petropavlovskaya St., Perm, 614990
D. А. Demin
Federal Center for Cardiovascular Surgery
Russian Federation
Russian Federation
Dmitry А. Demin, Neurologist
4, Pokrovskaya Roscha St., Astrakhan, 414011
References
1. Pan Y., Shi G. Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window. Front Neurol. 2021;12:593887. https://doi.org/10.3389/fneur.2021.593887.
2. Albers G.W., Marks M.P., Kemp S., Christensen S., Tsai J.P., Ortega-Gutierrez S. et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708–718. https://doi.org/10.1056/NEJMoa1713973.
3. Nogueira R.G., Jadhav A.P., Haussen D.C., Bonafe A., Budzik R.F., Bhuva P. et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11–21. https://doi.org/10.1056/NEJMoa1706442.
4. Grigoryan M., Haussen D.C., Hassan A.E., Lima A., Grossberg J., Rebello L.C. et al. Endovascular Treatment of Acute Ischemic Stroke Due to Tandem Occlusions: Large Multicenter Series and Systematic Review. Cerebrovasc Dis. 2016;41(5–6):306–312. https://doi.org/10.1159/000444069.
5. Brinster C.J., Sternbergh W.C. 3rd. Safety of urgent carotid endarterectomy following thrombolysis. J Cardiovasc Surg (Torino). 2020;61(2):149–158. https://doi.org/10.23736/S0021-9509.20.11179-0.
6. Barkova T.V., Alasheev A.M., Belkin A.A., Prazdnichkova E.V., Beltsova L.L. The efficacy and safety of telethrombolysis in a newly opened stroke unit. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(12–2):70–74. (In Russ.) https://doi.org/10.17116/jnevro201811812270.
7. Campbell B.C.V., Mitchell P.J., Churilov L., Yassi N., Kleinig T.J., Dowling R.J. et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018;378(17):1573–1582. https://doi.org/10.1056/NEJMoa1716405.
8. Gusev E.I., Martynov M.Y., Nikonov A.A., Shamalov N.A., Semenov M.P., Gerasimets E.A. et al. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallelgroup, non-inferiority trial. Lancet Neurol. 2021;20(9):721–728. https://doi.org/10.1016/S1474-4422(21)00210-6.
9. Berge E., Whiteley W., Audebert H., De Marchis G.M., Fonseca A.C., Padiglioni C. et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I–LXII. https://doi.org/10.1177/2396987321989865.
10. El-Wahsh S., Dunkerton S., Ang T., Winters H.S., Delcourt C. Current perspectives on neuroimaging techniques used to identify stroke mimics in clinical practice. Expert Rev Neurother. 2021;21(5):517–531. https://doi.org/10.1080/14737175.2021.1911650.
11. Moulin S., Leys D. Stroke mimics and chameleons. Curr Opin Neurol. 2019;32(1):54–59. https://doi.org/10.1097/WCO.0000000000000620.
12. Zinkstok S.M., Engelter S.T., Gensicke H., Lyrer P.A., Ringleb P.A., Artto V. et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke. 2013;44(4):1080–1084. https://doi.org/10.1161/STROKEAHA.111.000126.
13. Ali-Ahmed F., Federspiel J.J., Liang L., Xu H., Sevilis T., Hernandez A.F. et al. Intravenous Tissue Plasminogen Activator in Stroke Mimics. Circ Cardiovasc Qual Outcomes. 2019;12(8):e005609. https://doi.org/10.1161/CIRCOUTCOMES.119.005609.
14. Демин Д.А., Белопасов В.В., Асфандиярова Е.В., Журавлева Е.Н., Минтулаев И.С., Николаева Е.В. «Инсульты-хамелеоны». Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(4):72-80. https://doi.org/10.17116/jnevro201911904172. Demin D.A., Belopasov V.V., Asfandiiarova E.V., Zhuravleva E.N., Mintulaev I.S., Nikolaeva E.V. «Stroke chameleons». Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019;119(4):72-80. (In Russ.) https://doi.org/10.17116/jnevro201911904172.
15. Richoz B., Hugli O., Dami F., Carron P.N., Faouzi M., Michel P. Acute stroke chameleons in a university hospital: risk factors, circumstances, and outcomes. Neurology. 2015;85(6):505–511. https://doi.org/10.1212/wnl.0000000000001830.
16. Lees K.R., Emberson J., Blackwell L., Bluhmki E., Davis S.M., Donnan G.A. et al. Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials. Stroke. 2016;47(9):2373–2379. https://doi.org/10.1161/STROKEAHA.116.013644.
17. Wang X., Robinson T.G., Lee T.H., Li Q., Arima H., Bath P.M. et al. Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial. JAMA Neurol. 2017;74(11):1328–1335. https://doi.org/10.1001/jamaneurol.2017.2286.
18. Arora R., Salamon E., Katz J.M., Cox M., Saver J.L., Bhatt D.L. et al. Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age. Stroke. 2016;47(9):2347–2354. https://doi.org/10.1161/STROKEAHA.116.012241.
19. Fischer U., Baumgartner A., Arnold M., Nedeltchev K., Gralla J., De Marchis G.M. et al. What is a minor stroke? Stroke. 2010;41(4):661–666. https://doi.org/10.1161/STROKEAHA.109.572883.
20. Khatri P., Conaway M.R., Johnston K.C. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke. 2012;43(2):560–562. https://doi.org/10.1161/STROKEAHA.110.593897.
21. Khatri P., Kleindorfer D.O., Devlin T., Sawyer R.N.Jr., Starr M., Mejilla J. et al. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. JAMA. 2018;320(2):156–166. https://doi.org/10.1001/jama.2018.8496.
22. Emberson J., Lees K.R., Lyden P., Blackwell L., Albers G., Bluhmki E. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929–1935. https://doi.org/10.1016/S0140-6736(14)60584-5.
23. Romano J.G., Smith E.E., Liang L., Gardener H., Camp S., Shuey L. et al. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry. JAMA Neurol. 2015;72(4):423–431. https://doi.org/10.1001/jamaneurol.2014.4354.
24. Sykora M., Krebs S., Simader F., Gattringer T., Greisenegger S., Ferrari J. et al. Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1. Int J Stroke. 2022;17(1):109–119. https://doi.org/10.1177/1747493021991969.
25. Inoa V., Aron A.W., Staff I., Fortunato G., Sansing L.H. Lower NIH stroke scale scores are required to accurately predict a good prognosis in posterior circulation stroke. Cerebrovasc Dis. 2014;37(4):251–255. https://doi.org/10.1159/000358869.
26. Olivato S., Nizzoli S., Cavazzuti M., Casoni F., Nichelli P.F., Zini A. e-NIHSS: an Expanded National Institutes of Health Stroke Scale Weighted for Anterior and Posterior Circulation Strokes. J Stroke Cerebrovasc Dis. 2016;25(12):2953–2957. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.08.011.
27. Koh S., Lee S.E., Jung W.S., Choi J.W., Lee J.S., Hong J.M., Lee S.J. Predictors of Early Neurological Deterioration in Stroke Due to Vertebrobasilar Occlusion. Front Neurol. 2021;12:696042. https://doi.org/10.3389/fneur.2021.696042.
28. Keselman B., Gdovinová Z., Jatuzis D., Melo T.P.E., Vilionskis A., Cavallo R. et al. Safety and Outcomes of Intravenous Thrombolysis in Posterior Versus Anterior Circulation Stroke: Results From the Safe Implementation of Treatments in Stroke Registry and Meta-Analysis. Stroke. 2020;51(3):876–882. https://doi.org/10.1161/STROKEAHA.119.027071.
29. Cui Y., Meng W.H., Chen H.S. Early neurological deterioration after intravenous thrombolysis of anterior vs posterior circulation stroke: a secondary analysis of INTRECIS. Sci Rep. 2022;12(1):3163. https://doi.org/10.1038/s41598-022-07095-6.
30. Кулеш А.А., Демин Д.А., Гусева А.Л., Виноградов О.И., Парфенов В.А. Вестибулярное головокружение в неотложной неврологии. Российский неврологический журнал. 2021;(4):50–59. https://doi.org/10.30629/2658-7947-2021-26-4-50-59. Kulesh A.A., Dyomin D.A., Guseva A.L., Vinogradov O.I., Parfyonov V.A. Vestibular vertigo in emergency neurology. Russian Neurological Journal. 2021;(4):50–59. (In Russ.) https://doi.org/10.30629/2658-7947-2021-26-4-50-59.
31. Machner B., Choi J.H., Neumann A., Trillenberg P., Helmchen C. What guides decision-making on intravenous thrombolysis in acute vestibular syndrome and suspected ischemic stroke in the posterior circulation? J Neurol. 2021;268(1):249–264. https://doi.org/10.1007/s00415-020-10134-9.
32. Seners P., Turc G., Maïer B., Mas J.L., Oppenheim C., Baron J.C. Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis. Stroke. 2016;47(9):2409–2412. https://doi.org/10.1161/STROKEAHA.116.014181.
33. Sun H., Liu Y., Gong P., Zhang S., Zhou F., Zhou J. Intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign: A meta-analysis. Acta Neurol Scand. 2020;141(3):193–201. https://doi.org/10.1111/ane.13177.
34. Kharitonova T.V., Melo T.P., Andersen G., Egido J.A., Castillo J., Wahlgren N. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis. Stroke. 2013;44(9):2513–2518. https://doi.org/10.1161/STROKEAHA.111.000048.
35. Goyal M., Menon B.K., van Zwam W.H., Dippel D.W., Mitchell P.J., Demchuk A.M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–1731. https://doi.org/10.1016/S0140-6736(16)00163-X.
36. Wang Y., Wu X., Zhu C., Mossa-Basha M., Malhotra A. Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion: An Updated Meta-Analysis. Stroke. 2021;52(1):356–365. https://doi.org/10.1161/STROKEAHA.120.031477.
37. Fischer U., Kaesmacher J., Strbian D., Eker O., Cognard C., Plattner P.S. et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400(10346):104–115. https://doi.org/10.1016/S0140-6736(22)00537-2.
38. Mitchell P.J., Yan B., Churilov L., Dowling R.J., Bush S.J., Bivard A. et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blindedendpoint, randomised non-inferiority trial. Lancet. 2022;400(10346):116–125. https://doi.org/10.1016/S0140-6736(22)00564-5.
39. Powers W.J., Rabinstein A.A., Ackerson T., Adeoye O.M., Bambakidis N.C., Becker K. et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. https://doi.org/10.1161/STR.0000000000000211.
40. Turc G., Tsivgoulis G., Audebert H.J., Boogaarts H., Bhogal P., De Marchis G.M. et al. European Stroke Organisation – European Society for Minimally Invasive Neurological Therapy expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stroke and anterior circulation large vessel occlusion. Eur Stroke J. 2022;7(1):I–XXVI. https://doi.org/10.1177/23969873221076968.
41. Regenhardt R.W., Das A.S., Ohtomo R., Lo E.H., Ayata C., Gurol M.E. Pathophysiology of Lacunar Stroke: History’s Mysteries and Modern Interpretations. J Stroke Cerebrovasc Dis. 2019;28(8):2079–2097. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.05.006.
42. Giacomozzi S., Caso V., Agnelli G., Acciarresi M., Alberti A., Venti M. Lacunar stroke syndromes as predictors of lacunar and non-lacunar infarcts on neuroimaging: a hospital-based study. Intern Emerg Med. 2020;15(3):429–436. https://doi.org/10.1007/s11739-019-02193-2.
43. Matusevicius M., Paciaroni M., Caso V., Bottai M., Khurana D., de Bastos M. et al. Outcome after intravenous thrombolysis in patients with acute lacunar stroke: An observational study based on SITS international registry and a meta-analysis. Int J Stroke. 2019;14(9):878–886. https://doi.org/10.1177/1747493019840947.
44. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol. 2015;14(5):485–496. https://doi.org/10.1016/S1474-4422(15)00012-5.
45. Meretoja A., Keshtkaran M., Saver J.L., Tatlisumak T., Parsons M.W., Kaste M. et al. Stroke thrombolysis: save a minute, save a day. Stroke. 2014;45(4):1053–1058. https://doi.org/10.1161/STROKEAHA.113.002910.
46. Fonarow G.C., Zhao X., Smith E.E., Saver J.L., Reeves M.J., Bhatt D.L. et al. Doorto-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2014;311(16):1632–1640. https://doi.org/10.1001/jama.2014.3203.
47. Kamal N., Jeerakathil T., Stang J., Liu M., Rogers E., Smith E.E. et al. Provincial Door-to-Needle Improvement Initiative Results in Improved Patient Outcomes Across an Entire Population. Stroke. 2020;51(8):2339–2346. https://doi.org/10.1161/STROKEAHA.120.029734.
48. Rimmele D.L., Thomalla G. Wake-up stroke: clinical characteristics, imaging findings, and treatment option – an update. Front Neurol. 2014;5:35. https://doi.org/10.3389/fneur.2014.00035.
49. Campbell B.C.V., Ma H., Ringleb P.A., Parsons M.W., Churilov L., Bendszus M. et al. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data. Lancet. 2019;394(10193):139–147. https://doi.org/10.1016/S0140-6736(19)31053-0.
50. Thomalla G., Simonsen C.Z., Boutitie F., Andersen G., Berthezene Y., Cheng B. et al. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. N Engl J Med. 2018;379(7):611–622. https://doi.org/10.1056/NEJMoa1804355.
51. Ma H., Campbell B.C.V., Parsons M.W., Churilov L., Levi C.R., Hsu C. et al. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke. N Engl J Med. 2019;380(19):1795–1803. https://doi.org/10.1056/NEJMoa1813046.
52. Macha K., Hoelter P., Siedler G., Knott M., Schwab S., Doerfler A. et al. Multimodal CT or MRI for IV thrombolysis in ischemic stroke with unknown time of onset. Neurology. 2020;95(22):e2954–e2964. https://doi.org/10.1212/WNL.0000000000011059.
53. Yaghi S., Willey J.Z., Cucchiara B., Goldstein J.N., Gonzales N.R., Khatri P. et al. Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke. 2017;48(12):e343–e361. https://doi.org/10.1161/STR.0000000000000152.
54. Charbonnier G., Bonnet L., Biondi A., Moulin T. Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke. Front Neurol. 2021;11:629920. https://doi.org/10.3389/fneur.2020.629920.
55. Kulesh A.A., Syromyatnikova L.I., Golosova Yu.A., Shestakov V.V. The experience of using thrombolysis in patients with acute disturbances of cerebral circulation: efficacy, safety, predictors of outcome and hemorrhagic transformation. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(7):18–24. (In Russ.) https://doi.org/10.17116/jnevro20181187118.
56. Sandset E.C., Anderson C.S., Bath P.M., Christensen H., Fischer U., Gąsecki D. et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J. 2021;6(2):XLVIII–LXXXIX. https://doi.org/10.1177/23969873211012133.
57. Fröhlich K., Macha K., Gerner S.T., Bobinger T., Schmidt M., Dörfler A. et al. Angioedema in Stroke Patients With Thrombolysis. Stroke. 2019;50(7):1682–1687. https://doi.org/10.1161/STROKEAHA.119.025260.
58. Vigneron C., Lécluse A., Ronzière T., Bouillet L., Boccon-Gibod I., Gayet S. et al. Angioedema associated with thrombolysis for ischemic stroke: analysis of a case-control study. J Intern Med. 2019;286(6):702–710. https://doi.org/10.1111/joim.12962.
Review
For citations:
Кulesh АА, Demin DА. Intravenous thrombolysis in ischemic stroke: 10 rules for the practical neurologist. Meditsinskiy sovet = Medical Council. 2022;(21):175-183. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-21-175-183
Views:
548
Email this article 